AUG 01, 2016 5:54 AM PDT

How Lab Grown Brain Tissue Helps Parkinson's Research

When brain tissue is damaged by injury or disease, it’s irreplaceable. Unlike organ transplants or bone and skin grafts, the brain cannot be repaired by sticking on a few new cells. However, in a stunning new research study in Singapore, scientists have made advances in lab created mini versions of mid-brain tissue. Having these small bits of brain tissue will be a huge help for researchers who study Parkinson’s disease, Alzheimer’s and other forms of dementia.
 Lab grown brain tissue could help scientists understand Parkinson's disease
What the lab in Singapore has managed to create are actually three dimensional  miniature versions of certain parts of the human brain. In their study, the results are significant because the tissues grown there have both black pigment neuromelanin and functionally active dopaminergic neurons.
 
The human midbrain is the part of the brain that controls some major functions. Auditory processing, eye movements, vision and muscle movement are the main ones that the mid-brain regulates. Dopaminergic neurons are those that produce dopamine, a substance which is crucial for executive function including motivation, reward and impulse control. Dopamine needs to be balanced because when levels are high, impulsive control suffers and motor activity is increased. Dopamine levels that are too low lead to slower reaction times. In disorders like Parkinson’s disease (PD) dopamine bottoms out and results in the muscle stiffness and difficulty moving that is the hallmark of the disease.
 
Another factor in PD is neuromelanin. In patients with the disease, the tremors they experience are related to cell death in the mid-brain. It’s believed that these cells die from oxidative stress and that neuromelanin has a protective effect against cell death. Parkinson’s patients show a reduction in neuromelanin, so being able to grow tissue that includes it means that research into treatments can take a whole new direction. Given that there are anywhere from seven to 10 million people worldwide who are currently suffering from PD, and the likelihood of that number increasing in coming years, the ability for researchers to use this kind of tissue is groundbreaking. Up until now, any studies on neurodegenerative diseases had to be done using algorithms and simulations or on lab animals. The translation of these studies into human trials has not always been successful. Having actual pieces of brain tissue that are part of the disease process of PD, grown from stem cells, and containing these two key elements will allow researchers a much better foundation for their work.
 
The project was a collaboration of international organizations and scientists, all of whom are leaders in the field of Parkinson’s research.  Prof Ng Huck Hui from A*STAR's Genome Institute of Singapore (GIS) and Assistant Prof Shawn Je from Duke-NUS Medical School were the co-leaders of the project and were assisted by other collaborators from Singapore’s National Neuroscience Institute, the Lieber Institute for Brain Development, the Johns Hopkins University School of Medicine and Nanyang Technological University. It was funded by the Singapore National Medical Research Council's Translational Clinical Research (TCR) Programme In Parkinson's disease (PD) and A*STAR. In a press release, Shawn Je said,  “It is remarkable that our midbrain organoids mimic human midbrain development. The cells divide, cluster together in layers, and become electrically and chemically active in three-dimensional environment like our brain. Now we can really test how these mini brains react to existing or newly developed drugs before treating patients, which will be a game changer for drug development.” The video below has more information on the project.

 Sources:

 A*Star, Duke-NUS Medical School, National Neuroscience Institute
 
The Straits Times
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
SEP 14, 2020
Clinical & Molecular DX
Peek into the Inner Workings of the Spinal Cord
SEP 14, 2020
Peek into the Inner Workings of the Spinal Cord
Scientists have established a state-of-the-art method for observing and analyzing the complex flurry of neurological act ...
OCT 03, 2020
Clinical & Molecular DX
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
OCT 03, 2020
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or tho ...
OCT 21, 2020
Cannabis Sciences
Exercise Reverses Learning Impairments from Cannabinoid Issues
OCT 21, 2020
Exercise Reverses Learning Impairments from Cannabinoid Issues
While cannabinoids usually get attention for their recreational effects, these molecules play a role in several other pr ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 15, 2020
Neuroscience
Researchers Confirm Link Between Alzheimer's and Gut Bacteria
NOV 15, 2020
Researchers Confirm Link Between Alzheimer's and Gut Bacteria
Researchers from the University of Geneva in Switzerland have confirmed the link between an imbalance of gut bacteria an ...
Loading Comments...